Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
863.4 DKK | -0.09% | -4.70% | +11.84% |
02-27 | Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. | CI |
02-14 | COLOPLAST : Q1 24: Many more positives beyond the margin beat |
Chart calendar Coloplast A/S
Upcoming events on Coloplast A/S
Past events on Coloplast A/S
2024-03-04 | Carnegie Healthcare Conference |
2024-02-27 | UBS European Healthcare Conference |
2024-02-20 | Roadshow - Goldman Sachs |
2024-02-19 | Roadshow - Nordea |
2024-02-18 | Roadshow - Goldman Sachs |
2024-02-09 05:00 | Q1 2024 Earnings Call |
2024-02-09 01:30 | Q1 2024 Earnings Release |
2023-12-07 | Final dividend |
2023-12-07 09:30 | Annual General Meeting |
2023-11-09 05:00 | Q4 2023 Earnings Call |
2023-11-09 01:30 | Q4 2023 Earnings Release |
2023-09-28 02:00 | Citi European Healthcare Bus Tour |
2023-09-27 | SEB Autumn Seminar |
2023-09-21 09:15 | Nordea Healthcare Conference |
2023-09-19 08:00 | Investor Meeting - Jefferies |
2023-09-18 10:00 | Barclay EU Medtech Bus Tour |
2023-09-12 | Kepler Cheuvreux Autumn Conference |
2023-09-07 05:30 | Danske Bank UK Investor Conference |
2023-09-05 | Goldman Sachs European Medtech and Healthcare Services Conference |
2023-09-04 08:00 | Business Update Call |
Past dividends on Coloplast A/S
2023-12-07 | Final Payment 16 DKK |
2023-05-14 | Interim Payment 5 DKK |
2022-12-01 | Final Payment 15 DKK |
2022-05-08 | Interim Payment 5 DKK |
2021-12-02 | Final Payment 14 DKK |
2021-05-09 | Interim Payment 5 DKK |
2020-12-03 | Final Payment 13 DKK |
2020-05-10 | Interim Payment 5 DKK |
2019-12-05 | Final Payment 12 DKK |
2019-05-05 | Interim Payment 5 DKK |
Annual results
Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 17 939 17 927 0.07% | 18 544 18 619 -0.4% | 19 426 19 358 0.35% | 22 579 22 510 0.31% | 24 500 24 705 -0.83% | 27 207 |
EBITDA Million DKK | Released Forecast Spread | 6 207 6 257 -0.8% | 6 705 6 599 1.61% | 6 947 7 088 -1.98% | 7 840 7 701 1.8% | 7 914 8 073 -1.97% | 8 837 |
EBIT Million DKK | Released Forecast Spread | 5 556 5 602 -0.83% | 5 854 5 840 0.24% | 6 355 6 323 0.51% | 6 910 6 830 1.17% | 6 845 7 016 -2.44% | 7 593 |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 5 028 5 507 -8.7% | 5 466 5 524 -1.06% | 6 233 6 272 -0.62% | 6 127 6 242 -1.85% | 6 025 6 230 -3.29% | 6 851 |
Net income Million DKK | Released Forecast Spread | 3 873 4 246 -8.79% | 4 197 4 262 -1.53% | 4 825 4 792 0.69% | 4 706 4 807 -2.1% | 4 783 4 948 -3.33% | 5 330 |
EPS DKK | Released Forecast Spread | 18,2 20,0 -9.07% | 19,7 20,1 -2.06% | 22,6 22,5 0.54% | 22,1 22,1 -0.11% | 22,2 23,3 -4.73% | 23,9 |
Announcement Date | 05/11/19 | 03/11/20 | 01/11/21 | 07/11/22 | 09/11/23 | - |
Quarterly results
Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 5 169 5 073 1.89% | 5 502 5 432 1.28% | 5 849 5 698 2.66% | 6 059 6 051 0.14% | 6 105 6 090 0.25% | 6 061 6 053 0.14% | 6 108 6 223 -1.85% | 6 226 6 407 -2.83% | 12 334 12 439 -0.84% | 6 606 6 619 -0.2% | 6 675 | 13 310 | 6 850 | 7 011 | 13 909 | 7 281 | 7 275 |
EBITDA Million DKK | Released Forecast Spread | 1 824 1 775 2.78% | 1 922 1 742 10.35% | 2 021 2 014 0.36% | 2 073 2 043 1.49% | 2 035 2 087 -2.47% | 1 939 2 002 -3.16% | 1 949 2 062 -5.46% | 1 991 2 122 -6.17% | 3 940 4 074 -3.29% | 2 130 2 102 1.33% | 2 140 | 4 273 | 2 276 | 2 385 | 4 504 | 2 457 | 2 435 |
EBIT Million DKK | Released Forecast Spread | 1 649 1 595 3.4% | 1 686 1 674 0.69% | 1 761 1 744 0.96% | 1 814 1 784 1.67% | 1 774 1 769 0.27% | 1 671 1 751 -4.58% | 1 686 1 790 -5.81% | 1 714 1 841 -6.87% | 3 400 3 503 -2.94% | 1 822 1 786 2.04% | 1 834 | 3 659 | 1 932 | 1 996 | 3 870 | 2 124 | 2 106 |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 1 557 1 521 2.39% | 1 287 1 434 -10.26% | 1 671 1 629 2.56% | 1 612 1 638 -1.6% | 1 427 1 631 -12.48% | 1 461 1 612 -9.37% | 1 610 1 652 -2.55% | 1 527 1 682 -9.24% | 1 554 1 577 -1.46% | 1 649 | 1 754 | 1 845 | 1 941 | 1 963 | |||
Net income Million DKK | Released Forecast Spread | 1 207 1 188 1.58% | 980 1 195 -17.97% | 1 289 1 254 2.8% | 1 230 1 258 -2.24% | 1 127 1 311 -14.05% | 1 155 1 288 -10.31% | 1 272 1 308 -2.76% | 1 229 1 326 -7.29% | 1 212 1 260 -3.85% | 1 291 | 1 401 | 1 443 | 1 514 | 1 531 | |||
EPS DKK | Released Forecast Spread | 5,66 5,62 0.71% | 4,60 5,65 -18.65% | 6,06 5,95 1.86% | 5,79 6,01 -3.67% | 5,31 6,31 -15.85% | 5,44 6,11 -11.01% | 5,98 6,13 -2.4% | 5,47 6,27 -12.79% | 5,39 5,75 -6.31% | 5,82 | 6,30 | 6,47 | 6,93 | 7,01 | |||
Announcement Date | 25/01/22 | 05/05/22 | 17/08/22 | 07/11/22 | 03/02/23 | 11/05/23 | 17/08/23 | 09/11/23 | 09/11/23 | 09/02/24 | - | - | - | - | - | - | - |
2024-04-29 | ALLMED MEDICAL PRODUCTS CO.,LTD: Q1 2024 Earnings Release |
2024-04-29 | ALLMED MEDICAL PRODUCTS CO.,LTD: Q4 2023 Earnings Release |
2024-05-06 | HARTALEGA HOLDINGS: Q4 2024 Earnings Release (Projected) |
2024-05-06 | SRI TRANG GLOVES (THAILAND): Q1 2024 Earnings Release (Projected) |
2024-05-07 01:00 | COLOPLAST A/S: Q2 2024 Earnings Release |
2024-05-07 | GVS S.P.A.: Q1 2024 Earnings Release (Projected) |
2024-05-09 16:05 | FIGS, INC.: Q1 2024 Earnings Release |
2024-05-09 | NAKANISHI INC.: Q1 2024 Earnings Release |
2024-05-12 | RIVERSTONE HOLDINGS LIMITED: Q1 2024 Earnings Release (Projected) |
2024-05-14 | SUPERMAX CORPORATION: Q3 2024 Earnings Release (Projected) |
Past sector events for Coloplast A/S
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- COLO B Stock
- Calendar Coloplast A/S